An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers
Clinical trial NCT01466335 · COMPLETED
Trial details
- NCT number
- NCT01466335
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-27
- Primary completion
- 2012-03-05
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.